Picotamide v aspirin for type 2 diabetes mellitus and peripheral arterial disease*

Outcomes at 24 monthsPicotamideAspirinRRR (95% CI)NNT (CI)
*Composite endpoint  =  death and non-fatal cardiovascular events. Other abbreviations defined in glossary; RRR, NNT, and CI calculated from data in article.
All cause mortality2.8%5.1%45% (2 to 69)44 (22 to 1025)
Composite endpoint7.5%9.0%16% (–22 to 43) Not significant